LIPINUTRAGEN SRL, born in Bologna in December 2005 as spin-off company of the National Research Council (CNR), is the first
company that brings to the market an innovative approach of molecular medicine: cell membrane lipidomics and
NUTRILIPIDOMICS, molecular diagnostics to nutraceuticals and nutrition for a personalized approach in health care.
The scientific know-how and ethics distinguish the Company’s activity in the health market. Lipinutragen performs high-quality molecular analysis, as well as training of the persons involved in the health market, providing them with innovative tools for prevention, diagnosis and treatment with highly customized nutritional products.
Functionality and reliability
The analytical protocols applied by Lipinutragen are connected to the CNR research about cell membrane lipidomics, radical stress and trans fatty acid formation, carried out by the co-founders researchers, Dr. Chryssostomos Chatgilialoglu and Dr. Carla Ferreri. The Company R&D&I is based on rigorous scientific basis, knowledge and skills provided by the above internationally renowned scientists
The robotic unit, created and owned by Lipinutragen, with an advanced and unique in the world technology, is able to implement the analysis and automatize the cell selection concerning the mature erythrocyte from a small blood sample (500 microliter) and the membrane fatty acid sampling, making repeatable and reliable membrane lipidomic analysis.
Transparency and quality certified
- The Lipidomic Laboratory authorized by the ASL (Health Aut. PG 263274 08/11/2012) at the Research Area of CNR in Bologna;
- Scientifically validated analytical protocol;
- CE certification of the robotic unit created and owned by Lipinutragen.